HbA1c to Average Glucose (eAG) Calculator

Conversion Direction

Unit System

Quick preset

Estimated Average Glucose (eAG)

—

A1C

—

A1C (IFCC)

—

eAG (mg/dL)

—

eAG (mmol/L)

—

The ADA Standards of Care list an A1C below 7.0% as the target for most nonpregnant adults with diabetes (eAG below about 154 mg/dL). Enter a value to see where it falls.

A1C scale (%)

4.05.76.58.014.0

What Is HbA1c?

HbA1c — hemoglobin A1c, usually written A1C — is the fraction of hemoglobin in red blood cells that has glucose attached to it. Glucose binds to hemoglobin continuously through a non-enzymatic process called glycation, so the percentage of glycated hemoglobin rises and falls with average blood glucose over time.

Red blood cells live about 120 days. Because of that lifespan, an A1C result reflects average glucose over the previous two to three months, weighted toward the most recent weeks. A single day of unusual readings barely moves it, which is exactly why clinicians value it as a long-term marker of glycemic patterns.

Clinicians use A1C to assess long-term glucose trends, to screen for diabetes risk, and to monitor how stable glucose has been between visits. It complements — but does not replace — daily glucose readings, which capture the spikes and lows that any average necessarily hides. A flat average of 154 mg/dL and a wildly swinging average of 154 mg/dL produce the same A1C.

Most US laboratories report A1C as a percentage on the NGSP/DCCT scale. Many countries also use IFCC units (mmol/mol), the international scientific standard. Both describe the same blood sample; the calculator above converts between them, and the mg to mL calculator handles the unit conversions clinicians need when dosing liquid medications.

The ADAG Formula Explained

The conversion on this page comes from the A1c-Derived Average Glucose (ADAG) study, published by Nathan DM and colleagues in Diabetes Care in 2008. The researchers followed 507 adults — with type 1 diabetes, type 2 diabetes, and without diabetes — collecting roughly 2,700 glucose readings per participant through continuous glucose monitoring and frequent fingerstick testing over several months.

Plotting each participant’s A1C against their true mean glucose produced a tight linear relationship (R² = 0.84). The resulting regression line became the standard equation the American Diabetes Association adopted for translating A1C into estimated average glucose:

// ADAG equation — A1C to estimated average glucose
eAG (mg/dL) = 28.7 × A1C(%) − 46.7
// Reverse — average glucose back to A1C
A1C(%) = (eAG (mg/dL) + 46.7) ÷ 28.7
// Direct mmol/L form (same equation ÷ 18.018)
eAG (mmol/L) = 1.59 × A1C(%) − 2.59
// IFCC master equation — unit conversion, not a glucose estimate
IFCC (mmol/mol) = (A1C(%) − 2.15) × 10.929

The mmol/L form is the same equation divided through by 18.018, the molecular-weight conversion factor between mg/dL and mmol/L for glucose. The IFCC equation is the international “master equation” linking the NGSP percentage scale to IFCC units — a pure unit conversion, not a glucose estimate.

A worked example makes the arithmetic concrete. For an A1C of 7.0%: 28.7 × 7.0 = 200.9; 200.9 − 46.7 = 154.2 mg/dL; then 154.2 ÷ 18.018 ≈ 8.6 mmol/L. Running it backward from 200 mg/dL: (200 + 46.7) ÷ 28.7 ≈ 8.6%.

One honest caveat: the equation describes a population average. Any individual’s true mean glucose can sit above or below the regression line — the original study reported real scatter around it, which is why the result is called an estimate. The next section’s table applies the same equation across the full clinical range.

A1C to eAG Conversion Table

The table below lists every A1C from 4.0% to 14.0% in 0.1% steps with its estimated average glucose in mg/dL and mmol/L, calculated directly from the ADAG equation. The highlighted rows mark 5.7%, 6.5%, and 7.0% — the ADA’s prediabetes threshold, diabetes threshold, and common treatment target. Values are rounded: mg/dL to the nearest whole number, mmol/L to one decimal place.

A1C (%)	eAG (mg/dL)	eAG (mmol/L)
4.0%	68	3.8
4.1%	71	3.9
4.2%	74	4.1
4.3%	77	4.3
4.4%	80	4.4
4.5%	82	4.6
4.6%	85	4.7
4.7%	88	4.9
4.8%	91	5.1
4.9%	94	5.2
5.0%	97	5.4
5.1%	100	5.5
5.2%	103	5.7
5.3%	105	5.9
5.4%	108	6.0
5.5%	111	6.2
5.6%	114	6.3
5.7%	117	6.5
5.8%	120	6.6
5.9%	123	6.8
6.0%	126	7.0
6.1%	128	7.1
6.2%	131	7.3
6.3%	134	7.4
6.4%	137	7.6
6.5%	140	7.8
6.6%	143	7.9
6.7%	146	8.1
6.8%	148	8.2
6.9%	151	8.4
7.0%	154	8.6
7.1%	157	8.7
7.2%	160	8.9
7.3%	163	9.0
7.4%	166	9.2
7.5%	169	9.4
7.6%	171	9.5
7.7%	174	9.7
7.8%	177	9.8
7.9%	180	10.0
8.0%	183	10.2
8.1%	186	10.3
8.2%	189	10.5
8.3%	192	10.6
8.4%	194	10.8
8.5%	197	10.9
8.6%	200	11.1
8.7%	203	11.3
8.8%	206	11.4
8.9%	209	11.6
9.0%	212	11.7
9.1%	214	11.9
9.2%	217	12.1
9.3%	220	12.2
9.4%	223	12.4
9.5%	226	12.5
9.6%	229	12.7
9.7%	232	12.9
9.8%	235	13.0
9.9%	237	13.2
10.0%	240	13.3
10.1%	243	13.5
10.2%	246	13.7
10.3%	249	13.8
10.4%	252	14.0
10.5%	255	14.1
10.6%	258	14.3
10.7%	260	14.5
10.8%	263	14.6
10.9%	266	14.8
11.0%	269	14.9
11.1%	272	15.1
11.2%	275	15.2
11.3%	278	15.4
11.4%	280	15.6
11.5%	283	15.7
11.6%	286	15.9
11.7%	289	16.0
11.8%	292	16.2
11.9%	295	16.4
12.0%	298	16.5
12.1%	301	16.7
12.2%	303	16.8
12.3%	306	17.0
12.4%	309	17.2
12.5%	312	17.3
12.6%	315	17.5
12.7%	318	17.6
12.8%	321	17.8
12.9%	324	18.0
13.0%	326	18.1
13.1%	329	18.3
13.2%	332	18.4
13.3%	335	18.6
13.4%	338	18.8
13.5%	341	18.9
13.6%	344	19.1
13.7%	346	19.2
13.8%	349	19.4
13.9%	352	19.5
14.0%	355	19.7

What the Numbers Mean

A1C results fall into ranges the American Diabetes Association defines in its Standards of Care. These cut points describe population-level thresholds, and clinicians interpret any single result alongside symptoms, repeat testing, and other laboratory findings — not in isolation.

Range	A1C	eAG (mg/dL)	What it indicates
Normal range	Below 5.7%	Below 117	Average glucose in the typical range
Prediabetes range	5.7% – 6.4%	117 – 139	Above-normal average glucose; elevated diabetes risk
Diabetes range	6.5% or higher	140 or higher	Meets the ADA glycemic criterion for the diabetes range
ADA target (most adults with diabetes)	Below 7.0%	Below 154	Common treatment target in clinical guidelines

The 6.5% cut point is one of several criteria clinicians use when evaluating diabetes. A single elevated result is typically confirmed with repeat testing before any conclusion is drawn, because laboratory variation and the confounders described below can move the number.

The below-7.0% target applies to most nonpregnant adults with diabetes, but guidelines individualize it. Older adults, people with frequent hypoglycemia, and those with limited life expectancy often work with different targets set together with their clinician. The number is a guide for discussion, not a universal rule.

Limitations of A1C Conversion

The ADAG equation assumes normal red blood cell turnover and a typical hemoglobin molecule. Several common conditions break that assumption — and this is where A1C interpretation needs the most care. An eAG derived from a distorted A1C inherits the distortion.

Anemia and iron deficiency. Altered red blood cell production and lifespan shift A1C independent of glucose. Iron deficiency tends to raise A1C, while hemolytic anemias and recent blood loss lower it.
Hemoglobin variants. Sickle cell trait, hemoglobin C, and other variants can interfere with certain assay methods and shorten red blood cell survival, which lowers A1C relative to true average glucose. Some laboratories use methods unaffected by common variants — the lab report usually notes this.
Pregnancy. Increased red blood cell turnover in the second and third trimesters lowers A1C, and guidelines rely on glucose-based testing instead during pregnancy.
Chronic kidney disease. Uremia shortens red blood cell lifespan, and anemia treatments such as erythropoietin and iron alter the measurement. A1C often reads falsely low in advanced CKD and dialysis, which is why nephrologists interpret it cautiously. The GFR calculator estimates kidney filtration rate, the metric clinicians pair with A1C in this setting.
Recent transfusion or blood loss. Donor red blood cells dilute the measurement for weeks after a transfusion; acute blood loss has a similar distorting effect.
Rapid glucose changes. A1C lags behind reality. A recently corrected period of prolonged high glucose still shows in the number for weeks, and a new treatment regimen needs two to three months before its full effect appears.
Population variation. Studies have reported small systematic differences — for example, higher A1C at the same measured mean glucose in Black individuals compared with White individuals. The clinical significance is still debated, but the variation itself is documented in the literature.

When A1C is unreliable, clinicians turn to alternatives: fructosamine (reflecting roughly two to three weeks), glycated albumin, or continuous glucose monitoring metrics such as the Glucose Management Indicator (GMI). Each has its own limitations, which is why no single number ever tells the whole story.

Practical Tips for Reading Your Result

🧪

Compare like with like

eAG estimates a two-to-three-month average. A single fasting reading or one good day will not match it — and is not supposed to. Judge the estimate against your own longer-run meter or CGM average instead.

📊

Know your units before comparing

US labs and meters usually speak mg/dL and A1C %; many other countries use mmol/L and IFCC mmol/mol. Convert with the tabs above (mg/dL ÷ 18.018 = mmol/L) so you never compare across unit systems by accident.

🩸

Check the confounders first

Before reacting to a surprising A1C, run through the limitations list: anemia, pregnancy, a recent transfusion, kidney disease, or a hemoglobin variant. Any of these can move A1C without any change in glucose.

📝

Follow the trend, not the dot

Successive A1C results carry more meaning than any single value. A stable 7.2% and a falling 8.5% tell very different stories even though both sit above the common target.

Key Takeaways

HbA1c reflects average blood glucose over roughly the past 2–3 months; eAG translates that percentage into the mg/dL or mmol/L units shown on glucose meters.
The standard conversion is the ADAG equation — eAG (mg/dL) = 28.7 × A1C − 46.7 — derived from 507 participants in Nathan et al., Diabetes Care 2008.
ADA ranges: below 5.7% is the normal range, 5.7–6.4% the prediabetes range, 6.5% and above the diabetes range, with below 7.0% the target for most adults with diabetes.
eAG is a population-based estimate. Anemia, pregnancy, hemoglobin variants, kidney disease, and recent transfusions can distort A1C and everything derived from it.
This calculator is an educational reference. Laboratory A1C results and clinical context — interpreted with a licensed healthcare professional — determine care decisions.

Dr. Heart (Health Observer)
Medical Data Analyst · Editorial review, October 2026

All conversion formulas on this page are referenced against the ADAG study (Nathan DM et al., Diabetes Care 2008), the ADA Standards of Care, and the IFCC reference system for HbA1c measurement. The 101-value table was generated directly from the published ADAG equation and cross-checked against published reference values.

“Dr. Heart” is the editorial pen name of Eric Jason, a medical data analyst — not a licensed physician. Content is prepared for education and clinical reference, and health decisions always involve a licensed healthcare professional. Read more about the editorial team at Dr. Heart.

Frequently Asked Questions

Is eAG the same as a fingerstick average?

Not exactly. eAG is a calculated estimate derived from A1C using the ADAG regression equation, while a fingerstick average is the arithmetic mean of your meter readings. The two usually land close together, but test timing, missed readings, and conditions that alter red blood cell lifespan can open a gap between them.

Why doesn’t my meter average match my A1C-derived eAG?

Meter averages only include the moments you test, so overnight highs or post-meal spikes you never capture are missing from the mean. A1C reflects glucose around the clock over two to three months. Testing patterns, meter accuracy limits of around ±15%, and red blood cell factors can all shift A1C away from a simple meter mean.

Can A1C be wrong?

A1C can mislead when red blood cell turnover is abnormal. Iron-deficiency anemia, hemoglobin variants such as sickle cell trait, pregnancy, chronic kidney disease, recent transfusion, or blood loss can raise or lower A1C independent of glucose. In these situations clinicians may rely on fructosamine, glycated albumin, or CGM data instead.

What is a good A1C target?

Guidelines suggest an A1C below 7.0% for most nonpregnant adults with diabetes, which corresponds to an eAG under about 154 mg/dL. Targets are individualized: clinicians may set a tighter or looser goal based on age, hypoglycemia risk, life expectancy, and other conditions. The number is a guide for discussion, not a universal rule.

How is IFCC (mmol/mol) different from A1C %?

Both report the same measurement. A1C % uses the NGSP/DCCT scale familiar in the United States, while IFCC mmol/mol is the international scientific standard reporting millimoles of glycated hemoglobin per mole of total hemoglobin. They convert exactly: IFCC = (A1C% − 2.15) × 10.929. Most US labs report %, while many other countries report mmol/mol.

Sources

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478. doi:10.2337/dc08-0545
American Diabetes Association. Standards of Care in Diabetes—2026. Glycemic goals, A1C targets, and diagnostic criteria. diabetes.org
Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50(1):166-174. doi:10.1373/clinchem.2003.024802
National Glycohemoglobin Standardization Program (NGSP). IFCC–NGSP master equation and unit conversion reference. ngsp.org